• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体和人群在热带国家多个季节中流感抗体效价的变化轨迹。

Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country.

机构信息

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.

Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

出版信息

Am J Epidemiol. 2018 Jan 1;187(1):135-143. doi: 10.1093/aje/kwx201.

DOI:10.1093/aje/kwx201
PMID:29309522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5860523/
Abstract

Seasonal influenza epidemics occur year-round in the tropics, complicating the planning of vaccination programs. We built an individual-level longitudinal model of baseline antibody levels, time of infection, and the subsequent rise and decay of antibodies postinfection using influenza A(H1N1)pdm09 data from 2 sources in Singapore: 1) a noncommunity cohort with real-time polymerase chain reaction-confirmed infections and at least 1 serological sample collected from each participant between May and October 2009 (n = 118) and 2) a community cohort with up to 6 serological samples collected between May 2009 and October 2010 (n = 760). The model was hierarchical, to account for interval censoring and interindividual variation. Model parameters were estimated via a reversible jump Markov chain Monte Carlo algorithm using custom-designed R (https://www.r-project.org/) and C++ (https://isocpp.org/) code. After infection, antibody levels peaked at 4-7 weeks, with a half-life of 26.5 weeks, followed by a slower decrease up to 1 year to approximately preinfection levels. After the third wave, the seropositivity rate and the population-level antibody titer dropped to the same level as they were at the end of the first pandemic wave. The results of this analysis are consistent with the hypothesis that the population-level effect of individuals' waxing and waning antibodies influences influenza seasonality in the tropics.

摘要

季节性流感在热带地区全年流行,这使得疫苗接种计划的规划变得复杂。我们使用来自新加坡的 2 个数据源的甲型 H1N1pdm09 数据,建立了一个基于个体的纵向基线抗体水平、感染时间以及感染后抗体上升和下降的模型:1)实时聚合酶链反应确认感染的非社区队列,并且每个参与者至少在 2009 年 5 月至 10 月之间收集了 1 份血清样本(n = 118);2)社区队列,最多在 2009 年 5 月至 2010 年 10 月之间收集了 6 份血清样本(n = 760)。该模型是分层的,以考虑区间 censoring 和个体间的变异。通过使用定制的 R(https://www.r-project.org/)和 C++(https://isocpp.org/)代码的可逆跳跃马尔可夫链蒙特卡罗算法估计模型参数。感染后,抗体水平在 4-7 周时达到峰值,半衰期为 26.5 周,然后以较慢的速度下降,直到 1 年左右恢复到感染前的水平。在第三波之后,血清阳性率和人群抗体滴度下降到与第一波大流行结束时相同的水平。这项分析的结果与假设一致,即个体抗体的增减对人群水平的影响影响了热带地区的流感季节性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/11fbee50e7e8/kwx201f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/3ef963c99c86/kwx201f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/41363f6cd4ab/kwx201f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/c337e12270d5/kwx201f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/3c616d0fc026/kwx201f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/b1f0970c7f16/kwx201f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/11fbee50e7e8/kwx201f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/3ef963c99c86/kwx201f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/41363f6cd4ab/kwx201f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/c337e12270d5/kwx201f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/3c616d0fc026/kwx201f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/b1f0970c7f16/kwx201f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e85/5860523/11fbee50e7e8/kwx201f06.jpg

相似文献

1
Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country.个体和人群在热带国家多个季节中流感抗体效价的变化轨迹。
Am J Epidemiol. 2018 Jan 1;187(1):135-143. doi: 10.1093/aje/kwx201.
2
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
3
A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.在2009年甲型H1N1流感大流行出现一年后,很大一部分墨西哥人口仍易感染甲型H1N1流感病毒。
PLoS One. 2016 Mar 22;11(3):e0150428. doi: 10.1371/journal.pone.0150428. eCollection 2016.
4
Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.2010 年 11 月德国汉堡的大流行性流感和三价季节性流感疫苗接种以及自然感染后的甲型 H1N1pdm09 抗体。
Euro Surveill. 2012 Jan 12;17(2):20052.
5
[Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season].[2010 - 2011年流感季节后摩洛哥两个地区甲型H1N1流感大流行病毒的血清流行率]
Pathol Biol (Paris). 2013 Apr;61(2):83-6. doi: 10.1016/j.patbio.2012.05.004. Epub 2012 Jun 22.
6
Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.接种季节性三价流感疫苗诱导对大流行性 A(H1N1)2009 流感病毒的交叉反应性抗体应答:日本三个流感季节的纵向研究。
Microbiol Immunol. 2012 Dec;56(12):810-6. doi: 10.1111/j.1348-0421.2012.00511.x.
7
Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.比较老年人和医护人员接种季节性 H1N1 2009 流感疫苗前后对大流行性 H1N1 2009 流感病毒的中和抗体和细胞介导免疫应答。
Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.
8
Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.测定流感样病例和高危人群对 2009 年人感染流感 H1N1 病毒的抗体反应。
Asian Pac J Allergy Immunol. 2010 Mar;28(1):67-75.
9
Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.2009 年土耳其甲型 H1N1 流感大流行第一波后的血清流行率。
Jpn J Infect Dis. 2012;65(1):13-8.
10
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera.在非配对血清背景下解读流感血清流行病学研究。
Epidemiology. 2016 Jan;27(1):152-8. doi: 10.1097/EDE.0000000000000408.

引用本文的文献

1
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data.血清动力学:使用血清学数据进行流行病学推断方法的入门介绍与综合综述
Epidemics. 2024 Dec;49:100806. doi: 10.1016/j.epidem.2024.100806. Epub 2024 Nov 30.
2
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer.病毒免疫前史与免疫检查点阻断的疗效:广泛的血清抗体谱预测非小细胞肺癌的结局。
J Immunother Cancer. 2024 Nov 28;12(11):e009931. doi: 10.1136/jitc-2024-009931.
3
Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.

本文引用的文献

1
Immune history profoundly affects broadly protective B cell responses to influenza.免疫史深刻影响对流感的广泛保护性B细胞反应。
Sci Transl Med. 2015 Dec 2;7(316):316ra192. doi: 10.1126/scitranslmed.aad0522.
2
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera.在非配对血清背景下解读流感血清流行病学研究。
Epidemiology. 2016 Jan;27(1):152-8. doi: 10.1097/EDE.0000000000000408.
3
Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials.
快速分子诊断检测对出现病毒性呼吸道症状患者的临床影响:一项系统文献综述
PLoS One. 2024 Jun 13;19(6):e0303560. doi: 10.1371/journal.pone.0303560. eCollection 2024.
4
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.灭活脊髓灰质炎病毒疫苗加强针可降低口服脊髓灰质炎疫苗初免个体出现新冠病毒感染相关结果的可能性。
Vaccines (Basel). 2024 Feb 20;12(3):219. doi: 10.3390/vaccines12030219.
5
Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older.75岁及以上社区居住老年人中疫苗诱导的血凝抑制抗体滴度的季节间下降以及针对流感的既往体液免疫的影响因素
Immun Ageing. 2023 Jul 31;20(1):38. doi: 10.1186/s12979-023-00362-8.
6
Pathogen Exposure in White Whales () in Svalbard, Norway.挪威斯瓦尔巴群岛白鲸( )中的病原体暴露情况
Pathogens. 2022 Dec 29;12(1):58. doi: 10.3390/pathogens12010058.
7
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis.与学术医疗中心医护人员对 BNT162b2 COVID-19 疫苗的抗体反应差异相关的人口统计学和临床特征:一项纵向队列分析。
BMJ Open. 2022 May 24;12(5):e059994. doi: 10.1136/bmjopen-2021-059994.
8
Reconstructing antibody dynamics to estimate the risk of influenza virus infection.重建抗体动态以估计流感病毒感染的风险。
Nat Commun. 2022 Mar 23;13(1):1557. doi: 10.1038/s41467-022-29310-8.
9
Age-seroprevalence curves for the multi-strain structure of influenza A virus.甲型流感病毒多株结构的年龄血清流行率曲线。
Nat Commun. 2021 Nov 18;12(1):6680. doi: 10.1038/s41467-021-26948-8.
10
Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2.感染严重急性呼吸综合征冠状病毒 2 后 Spike 蛋白抗体的长期持久性和抗体动力学的预测建模。
Clin Infect Dis. 2022 Apr 9;74(7):1220-1229. doi: 10.1093/cid/ciab607.
在疫苗试验中通过血凝抑制试验测定流感病毒感染防护效果的量化评估
Epidemiology. 2016 Jan;27(1):143-51. doi: 10.1097/EDE.0000000000000402.
4
Randomness of Dengue Outbreaks on the Equator.赤道地区登革热疫情的随机性
Emerg Infect Dis. 2015 Sep;21(9):1651-3. doi: 10.3201/eid2109.141030.
5
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.2013 - 2014年流感季节中年成年人非典型H1N1感染的潜在抗原学解释。
Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15798-803. doi: 10.1073/pnas.1409171111. Epub 2014 Oct 20.
6
Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.在新加坡的一组血清转化成年人中,通过血凝抑制和病毒微量中和试验测定对大流行性流感 A(H1N1-2009)抗体滴度的下降率。
BMC Infect Dis. 2014 Jul 28;14:414. doi: 10.1186/1471-2334-14-414.
7
Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia.亚洲南部和东南部热带及亚热带地区的流感季节性与疫苗接种时机
Bull World Health Organ. 2014 May 1;92(5):318-30. doi: 10.2471/BLT.13.124412. Epub 2014 Feb 24.
8
Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013.2010 - 2013年新加坡军事人员中季节性流感疫苗接种对实验室确诊的流感相关感染的有效性
Influenza Other Respir Viruses. 2014 Sep;8(5):557-66. doi: 10.1111/irv.12256. Epub 2014 May 14.
9
Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.评估流感疫苗接种计划的最佳目标人群:一项证据综合和建模研究。
PLoS Med. 2013 Oct;10(10):e1001527. doi: 10.1371/journal.pmed.1001527. Epub 2013 Oct 8.
10
Immune history shapes specificity of pandemic H1N1 influenza antibody responses.免疫史塑造了大流行性 H1N1 流感抗体反应的特异性。
J Exp Med. 2013 Jul 29;210(8):1493-500. doi: 10.1084/jem.20130212. Epub 2013 Jul 15.